Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
This report studies the global IBS-C Drugs market, analyzes and researches the IBS-C Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, IBS-C Drugs can be split into
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Other
Market segment by Application, IBS-C Drugs can be split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global IBS-C Drugs Market Size, Status and Forecast 2024
1 Industry Overview of IBS-C Drugs
1.1 IBS-C Drugs Market Overview
1.1.1 IBS-C Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global IBS-C Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 IBS-C Drugs Market by Type
1.3.1 Linaclotide
1.3.2 Lubiprostone
1.3.3 Osmotic Laxatives
1.3.4 Stimulant Laxatives
1.3.5 Other
1.4 IBS-C Drugs Market by End Users/Application
1.4.1 Hospital Pharmacies
1.4.2 Retail Pharmacies
1.4.3 Online Pharmacies
2 Global IBS-C Drugs Competition Analysis by Players
2.1 IBS-C Drugs Market Size (Value) by Players (2016 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Catalent Pharmaceuticals Solutions
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Nestle
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Abbott Laboratories
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Synergy Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Sucampo Pharmaceuticals
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Novartis Pharma Ag
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Astellas Pharmaceuticals
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Ardelyx, Inc
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Synthetic Biologics, Inc
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Teva Pharmaceutical Industries
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 IBS-C Drugs Revenue (Value) (2014-2019)
3.10.5 Recent Developments
3.11 Bama-Geve, SLU
3.12 Ferring BV
3.13 Ironwood Pharmaceuticals, Inc
3.14 Salix Pharmaceuticals Ltd
3.15 Norgine B.V
3.16 Prometheus Laboratories Inc
3.17 Actavis Nordic A/S
3.18 Albireo Pharma Inc
3.19 Yuhan Corp
3.20 Astrazeneca Plc
3.21 The Menarini Group
3.22 Ono Pharmaceutical Co., Ltd
4 Global IBS-C Drugs Market Size by Type and Application (2014-2019)
4.1 Global IBS-C Drugs Market Size by Type (2014-2019)
4.2 Global IBS-C Drugs Market Size by Application (2014-2019)
4.3 Potential Application of IBS-C Drugs in Future
4.4 Top Consumer/End Users of IBS-C Drugs
5 United States IBS-C Drugs Development Status and Outlook
5.1 United States IBS-C Drugs Market Size (2014-2019)
5.2 United States IBS-C Drugs Market Size and Market Share by Players (2016 and 2019)
6 EU IBS-C Drugs Development Status and Outlook
6.1 EU IBS-C Drugs Market Size (2014-2019)
6.2 EU IBS-C Drugs Market Size and Market Share by Players (2016 and 2019)
7 Japan IBS-C Drugs Development Status and Outlook
7.1 Japan IBS-C Drugs Market Size (2014-2019)
7.2 Japan IBS-C Drugs Market Size and Market Share by Players (2016 and 2019)
8 China IBS-C Drugs Development Status and Outlook
8.1 China IBS-C Drugs Market Size (2014-2019)
8.2 China IBS-C Drugs Market Size and Market Share by Players (2016 and 2019)
9 India IBS-C Drugs Development Status and Outlook
9.1 India IBS-C Drugs Market Size (2014-2019)
9.2 India IBS-C Drugs Market Size and Market Share by Players (2016 and 2019)
10 Southeast Asia IBS-C Drugs Development Status and Outlook
10.1 Southeast Asia IBS-C Drugs Market Size (2014-2019)
10.2 Southeast Asia IBS-C Drugs Market Size and Market Share by Players (2016 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2024)
11.1 Global IBS-C Drugs Market Size (Value) by Regions (2019-2024)
11.1.1 United States IBS-C Drugs Revenue and Growth Rate (2019-2024)
11.1.2 EU IBS-C Drugs Revenue and Growth Rate (2019-2024)
11.1.3 Japan IBS-C Drugs Revenue and Growth Rate (2019-2024)
11.1.4 China IBS-C Drugs Revenue and Growth Rate (2019-2024)
11.1.5 India IBS-C Drugs Revenue and Growth Rate (2019-2024)
11.1.6 Southeast Asia IBS-C Drugs Revenue and Growth Rate (2019-2024)
11.2 Global IBS-C Drugs Market Size (Value) by Type (2019-2024)
11.3 Global IBS-C Drugs Market Size by Application (2019-2024)
12 IBS-C Drugs Market Dynamics
12.1 IBS-C Drugs Market Opportunities
12.2 IBS-C Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 IBS-C Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 IBS-C Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
